UroGen's Chief Medical Officer Sells $400K in Stock Following Significant Share Price Increase
Mark Schoenberg, UroGen Pharma Ltd.'s Chief Medical Officer, sold $400,000 worth of shares on July 9, 2026 under a pre-established trading plan. The sale occurred after the stock had risen by 191%, with shares closing at $40.23 and the company's market cap reaching $2 billion.
Tickers: $URGN